• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状的免疫检查点抑制剂相关肺炎的临床和放射学特征与疾病严重程度的关联

Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis.

作者信息

Zhang Qian, Tao Xiuli, Zhao Shijun, Li Ning, Wang Shuhang, Wu Ning

机构信息

Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

出版信息

Diagnostics (Basel). 2023 Feb 12;13(4):691. doi: 10.3390/diagnostics13040691.

DOI:10.3390/diagnostics13040691
PMID:36832178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9955572/
Abstract

OBJECTIVES

To investigate the predictive ability of clinical and chest computed tomography (CT) features to predict the severity of symptomatic immune checkpoint inhibitor-related pneumonitis (CIP).

METHODS

This study included 34 patients diagnosed with symptomatic CIP (grades 2-5) and divided into mild (grade 2) and severe CIP (grades 3-5) groups. The groups' clinical and chest CT features were analyzed. Three manual scores (extent, image finding, and clinical symptom scores) were conducted to evaluate the diagnostic performance alone and in combination.

RESULTS

There were 20 cases of mild CIP and 14 cases of severe CIP. More severe CIP occurred within 3 months than after 3 months (11 vs. 3 cases, = 0.038). Severe CIP was significantly associated with fever ( < 0.001) and the acute interstitial pneumonia/acute respiratory distress syndrome pattern ( = 0.001). The diagnostic performance of chest CT scores (extent score and image finding score) was better than that of clinical symptom score. The combination of the three scores demonstrated the best diagnostic value, with an area under the receiver operating characteristic curve of 0.948.

CONCLUSIONS

The clinical and chest CT features have important application value in assessing the disease severity of symptomatic CIP. We recommend the routine use of chest CT in a comprehensive clinical evaluation.

摘要

目的

探讨临床及胸部计算机断层扫描(CT)特征对有症状的免疫检查点抑制剂相关肺炎(CIP)严重程度的预测能力。

方法

本研究纳入34例诊断为有症状CIP(2 - 5级)的患者,并分为轻度(2级)和重度CIP(3 - 5级)组。分析两组的临床及胸部CT特征。进行三项人工评分(范围、影像表现和临床症状评分)以单独及联合评估诊断性能。

结果

有20例轻度CIP和14例重度CIP。重度CIP在3个月内发生的比3个月后更多(11例对3例,P = 0.038)。重度CIP与发热(P < 0.001)及急性间质性肺炎/急性呼吸窘迫综合征模式(P = 0.001)显著相关。胸部CT评分(范围评分和影像表现评分)的诊断性能优于临床症状评分。三项评分联合显示出最佳诊断价值,受试者操作特征曲线下面积为0.948。

结论

临床及胸部CT特征在评估有症状CIP的疾病严重程度方面具有重要应用价值。我们建议在全面临床评估中常规使用胸部CT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/534984400834/diagnostics-13-00691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/b2ca1e908660/diagnostics-13-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/daa0c8fc0d45/diagnostics-13-00691-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/534984400834/diagnostics-13-00691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/b2ca1e908660/diagnostics-13-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/daa0c8fc0d45/diagnostics-13-00691-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b2/9955572/534984400834/diagnostics-13-00691-g003.jpg

相似文献

1
Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis.有症状的免疫检查点抑制剂相关肺炎的临床和放射学特征与疾病严重程度的关联
Diagnostics (Basel). 2023 Feb 12;13(4):691. doi: 10.3390/diagnostics13040691.
2
[Clinical and chest CT features of immune checkpoint inhibitor-related pneumonitis].免疫检查点抑制剂相关肺炎的临床及胸部CT特征
Zhonghua Zhong Liu Za Zhi. 2023 Feb 23;45(2):182-187. doi: 10.3760/cma.j.cn112152-20211123-00869.
3
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.免疫检查点抑制剂相关肺炎的临床特征和管理:一项单机构回顾性研究。
Cancer Med. 2021 Jan;10(1):188-198. doi: 10.1002/cam4.3600. Epub 2020 Nov 19.
4
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer.免疫检查点抑制剂治疗非小细胞肺癌重度级别的免疫检查点抑制剂性肺炎患者的高死亡率和低治疗效果。
Thorac Cancer. 2019 Oct;10(10):2006-2012. doi: 10.1111/1759-7714.13187. Epub 2019 Sep 3.
5
[Clinical features and prognostic analysis of checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer].[非小细胞肺癌患者检查点抑制剂肺炎的临床特征及预后分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Mar 12;47(3):207-213. doi: 10.3760/cma.j.cn112147-20231003-00210.
6
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis.拟议的临床阶段,以改善免疫检查点抑制剂相关肺炎的个体化治疗。
Front Immunol. 2022 Jul 20;13:935779. doi: 10.3389/fimmu.2022.935779. eCollection 2022.
7
A Novel Workflow to Create a Checkpoint Inhibitor Pneumonitis Patient Registry.创建检查点抑制剂肺炎患者登记处的新型工作流程。
Cureus. 2023 Feb 6;15(2):e34683. doi: 10.7759/cureus.34683. eCollection 2023 Feb.
8
Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease.免疫检查点抑制剂相关肺炎在合并慢性阻塞性肺疾病的非小细胞肺癌患者中的临床转归和危险因素。
BMC Pulm Med. 2022 Dec 1;22(1):458. doi: 10.1186/s12890-022-02190-w.
9
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.放射性肺炎与免疫检查点抑制剂相关性肺炎:不同的影像学形态。
Oncologist. 2021 Oct;26(10):e1822-e1832. doi: 10.1002/onco.13900. Epub 2021 Aug 4.
10
High-Resolution CT Patterns of Anti-PD1 Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer.肺癌患者中抗程序性死亡蛋白1(PD1)检查点抑制剂相关肺炎的高分辨率CT表现
J Comput Assist Tomogr. 2024;48(6):930-935. doi: 10.1097/RCT.0000000000001643. Epub 2024 Aug 12.

引用本文的文献

1
Radiomics and Deep Learning Prediction of Immunotherapy-Induced Pneumonitis From Computed Tomography.基于计算机断层扫描的放射组学和深度学习对免疫治疗引起的肺炎的预测
JCO Clin Cancer Inform. 2025 Feb;9:e2400198. doi: 10.1200/CCI-24-00198. Epub 2025 Feb 20.
2
Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis.放射组学在免疫检查点抑制剂相关肺炎的非小细胞肺癌患者中的临床应用。
Front Immunol. 2023 Sep 20;14:1251645. doi: 10.3389/fimmu.2023.1251645. eCollection 2023.

本文引用的文献

1
Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis.早发性和晚发性非小细胞肺癌免疫检查点抑制剂相关肺炎的影像学特征和预后。
BMC Cancer. 2021 May 29;21(1):634. doi: 10.1186/s12885-021-08353-y.
2
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society.胸部 CT 诊断与分子靶向药物和免疫检查点抑制剂治疗患者药物性肺炎的临床处理:弗勒施纳学会立场文件。
Chest. 2021 Mar;159(3):1107-1125. doi: 10.1016/j.chest.2020.11.027. Epub 2021 Jan 12.
3
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
免疫检查点抑制剂相关肺炎的临床特征和管理:一项单机构回顾性研究。
Cancer Med. 2021 Jan;10(1):188-198. doi: 10.1002/cam4.3600. Epub 2020 Nov 19.
4
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.与免疫检查点抑制剂治疗非小细胞肺癌相关的多系统免疫相关不良事件。
JAMA Oncol. 2020 Dec 1;6(12):1952-1956. doi: 10.1001/jamaoncol.2020.5012.
5
Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.免疫检查点抑制剂相关肺炎在肺癌及非肺癌中的临床和放射学特征。
Br J Radiol. 2020 Nov 1;93(1115):20200409. doi: 10.1259/bjr.20200409. Epub 2020 Aug 12.
6
Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.肺癌患者症状性放射性肺炎的放射学表现:与临床严重程度和结局相关的影像学预测因素。
Lung Cancer. 2020 Jul;145:132-139. doi: 10.1016/j.lungcan.2020.03.023. Epub 2020 Apr 30.
7
High-resolution CT features of the COVID-19 infection in Nanchong City: Initial and follow-up changes among different clinical types.南充市新型冠状病毒肺炎感染的高分辨率CT特征:不同临床类型的初始及随访变化
Radiol Infect Dis. 2020 Jun;7(2):71-77. doi: 10.1016/j.jrid.2020.05.001. Epub 2020 May 13.
8
Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.抗PD-1治疗所致肺炎的放射学特征的预后意义
Cancer Med. 2020 May;9(9):3070-3077. doi: 10.1002/cam4.2974. Epub 2020 Mar 9.
9
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.帕博利珠单抗治疗非结直肠癌高度微卫星不稳定/错配修复缺陷型癌症患者的疗效:来自 II 期 KEYNOTE-158 研究的结果。
J Clin Oncol. 2020 Jan 1;38(1):1-10. doi: 10.1200/JCO.19.02105. Epub 2019 Nov 4.
10
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.帕博利珠单抗单药或联合化疗对比西妥昔单抗联合化疗用于治疗复发性或转移性头颈部鳞状细胞癌(KEYNOTE-048):一项随机、开放标签、III 期研究。
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.